This Article Full Text Full Text (PDF) All Versions of this Article: 19/6/1516    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamrazi, A. Articles by Katzenellenbogen, J. A. Search for Related Content PubMed PubMed Citation Articles by Tamrazi, A. Articles by Katzenellenbogen, J. A.

Coactivator Proteins as Determinants of Estrogen Receptor Structure and Function: Spectroscopic Evidence for a Novel Coactivator-Stabilized Receptor Conformation

Department of Chemistry, University of Illinois, Urbana, Illinois 61801

Address all correspondence and requests for reprints to: John A. Katzenellenbogen, Department of Chemistry, University of Illinois, 600 South Mathews Avenue, Urbana, Illinois 61801. E-mail: jkatzene{at}uiuc.edu.

The direct regulation of gene transcription by nuclear receptors, such as the estrogen receptor (ER), involves not just ligand and DNA binding but the recruitment of coregulators. Typically, recruitment of p160 coactivator proteins to agonist-liganded ER is considered to be unidirectional, with ligand binding stabilizing an ER ligand binding domain (LBD) conformation that favors coactivator interaction. Using fluorophore-labeled ER-LBDs, we present evidence for a pronounced stabilization of ER conformation that results from coactivator binding, manifest by decreased ER sensitivity to proteases and reduced conformational dynamics, as well as for the formation of a novel coactivator-stabilized (costabilized) receptor conformation, that can be conveniently monitored by the generation of an excimer emission from pyrene-labeled ER-LBDs. This costabilized conformation may embody features required to support ER transcriptional activity. Different classes of coactivator proteins combine with estrogen agonists of different structure to elicit varying degrees of this receptor stabilization, and antagonists and coactivator binding inhibitors disfavor the costabilized conformation. Remarkably, high concentrations of coactivators engender this conformation even in apo- and antagonist-bound ERs (more so with selective ER modulators than with pure antagonists), providing an in vitro model for the development of resistance to hormone therapy in breast cancer.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα

Coregulators:   TRAP220  |  SRC-1  |  AIB1

Ligands:   17β-Estradiol  |  Diethylstilbestrol  |  4-Hydroxytamoxifen  |  Raloxifene

This article has been cited by other articles:

				M. T. Sonoda, L. Martinez, P. Webb, M. S. Skaf, and I. Polikarpov Ligand Dissociation from Estrogen Receptor Is Mediated by Receptor Dimerization: Evidence from Molecular Dynamics Simulations Mol. Endocrinol., July 1, 2008; 22(7): 1565 - 1578. [Abstract] [Full Text] [PDF]

				S. Y. Dai, M. J. Chalmers, J. Bruning, K. S. Bramlett, H. E. Osborne, C. Montrose-Rafizadeh, R. J. Barr, Y. Wang, M. Wang, T. P. Burris, et al. Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method PNAS, May 20, 2008; 105(20): 7171 - 7176. [Abstract] [Full Text] [PDF]

				T. Kirkegaard, L. M. McGlynn, F. M. Campbell, S. Muller, S. M. Tovey, B. Dunne, K. V. Nielsen, T. G. Cooke, and J. M.S. Bartlett Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor-Positive Tumors of Tamoxifen-Treated Breast Cancer Patients Clin. Cancer Res., March 1, 2007; 13(5): 1405 - 1411. [Abstract] [Full Text] [PDF]

				V. S. Likhite, F. Stossi, K. Kim, B. S. Katzenellenbogen, and J. A. Katzenellenbogen Kinase-Specific Phosphorylation of the Estrogen Receptor Changes Receptor Interactions with Ligand, Deoxyribonucleic Acid, and Coregulators Associated with Alterations in Estrogen and Tamoxifen Activity Mol. Endocrinol., December 1, 2006; 20(12): 3120 - 3132. [Abstract] [Full Text] [PDF]

				F. F. Zheng, R.-C. Wu, C. L. Smith, and B. W. O'Malley Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor Mol. Cell. Biol., September 15, 2005; 25(18): 8273 - 8284. [Abstract] [Full Text] [PDF]